269 related articles for article (PubMed ID: 17614094)
1. Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument.
Wettergren L; Sprangers M; Björkholm M; Langius-Eklöf A
Psychooncology; 2008 Apr; 17(4):338-46. PubMed ID: 17614094
[TBL] [Abstract][Full Text] [Related]
2. Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation.
Frick E; Borasio GD; Zehentner H; Fischer N; Bumeder I
Psychooncology; 2004 Feb; 13(2):116-24. PubMed ID: 14872530
[TBL] [Abstract][Full Text] [Related]
3. Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus).
Carlson LE; Bultz BD; Morris DG
Health Qual Life Outcomes; 2005 Jan; 3():7. PubMed ID: 15676074
[TBL] [Abstract][Full Text] [Related]
4. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
5. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Distress Thermometer with bone marrow transplant patients.
Ransom S; Jacobsen PB; Booth-Jones M
Psychooncology; 2006 Jul; 15(7):604-12. PubMed ID: 16208733
[TBL] [Abstract][Full Text] [Related]
7. The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation.
Hjermstad MJ; Evensen SA; Kvaløy SO; Loge JH; Fayers PM; Kaasa S
Psychooncology; 2003 Dec; 12(8):803-13. PubMed ID: 14681953
[TBL] [Abstract][Full Text] [Related]
8. Health related quality of life in stem cell transplantation: clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19).
Andersson I; Hjermstad M; Stockelberg D; Persson LO
Acta Oncol; 2008; 47(2):275-85. PubMed ID: 18210301
[TBL] [Abstract][Full Text] [Related]
9. [The quality of life after stem cell transplantation: problems with fatigue, sexuality, finances and employment].
Hendriks MG; van Beijsterveldt BC; Schouten HC
Ned Tijdschr Geneeskd; 1998 May; 142(20):1152-5. PubMed ID: 9623238
[TBL] [Abstract][Full Text] [Related]
10. Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation?
Frick E; Motzke C; Fischer N; Busch R; Bumeder I
Psychooncology; 2005 Sep; 14(9):759-70. PubMed ID: 15744779
[TBL] [Abstract][Full Text] [Related]
11. [Utility of the questionnaire for quality of life EORTC-QLQ-C30 in psycho-oncological outcome research].
Determann MM; Kollenbaum VE; Henne-Bruns D
Zentralbl Chir; 2004 Jan; 129(1):14-7. PubMed ID: 15011106
[TBL] [Abstract][Full Text] [Related]
12. Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?
Hjermstad M; Holte H; Evensen S; Fayers P; Kaasa S
Bone Marrow Transplant; 1999 Oct; 24(8):911-8. PubMed ID: 10516705
[TBL] [Abstract][Full Text] [Related]
13. Health related quality of life in patients with multiple myeloma undergoing a double transplantation.
Uyl-de Groot CA; Buijt I; Gloudemans IJ; Ossenkoppele GJ; Berg HP; Huijgens PC
Eur J Haematol; 2005 Feb; 74(2):136-43. PubMed ID: 15654905
[TBL] [Abstract][Full Text] [Related]
14. Individualized assessment of quality of life in idiopathic Parkinson's disease.
Lee MA; Walker RW; Hildreth AJ; Prentice WM
Mov Disord; 2006 Nov; 21(11):1929-34. PubMed ID: 16986143
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
[TBL] [Abstract][Full Text] [Related]
16. Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation.
Sherman AC; Simonton S; Latif U; Plante TG; Anaissie EJ
Biol Blood Marrow Transplant; 2009 Jan; 15(1):12-20. PubMed ID: 19135938
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls.
Kopp M; Holzner B; Meraner V; Sperner-Unterweger B; Kemmler G; Nguyen-Van-Tam DP; Nachbaur D
Eur J Haematol; 2005 Apr; 74(4):304-8. PubMed ID: 15777342
[TBL] [Abstract][Full Text] [Related]
18. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
[TBL] [Abstract][Full Text] [Related]
19. Differences in quality of life modalities give rise to needs of individual support in patients with ALS and their next of kin.
Olsson AG; Markhede I; Strang S; Persson LI
Palliat Support Care; 2010 Mar; 8(1):75-82. PubMed ID: 20163763
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning.
Andersson I; Ahlberg K; Stockelberg D; Brune M; Persson LO
Cancer Nurs; 2009; 32(4):325-34. PubMed ID: 19444087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
